P727: REFINING RISK STRATIFICATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML): A COMPREHENSIVE ASSESSMENT OF THE IPSS-M AND OTHER MOLECULARLY INTEGRATED PROGNOSTIC MODELS

• Luis E. Aguirre,
• Akriti Jain,
• Somedeb Ball,
• Najla Al Ali,
• David Sallman,
• Andrew Kuykendall,
• Onyee Chan,
• Zhuoer Xie,
• Alison Walker,
• Kendra Sweet,
• Jeffrey Lancet,
• Eric Padron,
• Rami S. Komrokji

Affiliations

Luis E. Aguirre

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

Akriti Jain

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

Somedeb Ball

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

Najla Al Ali

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

David Sallman

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

Andrew Kuykendall

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

Onyee Chan

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

Zhuoer Xie

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

Alison Walker

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

Kendra Sweet

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

Jeffrey Lancet

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

Eric Padron

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States

Rami S. Komrokji

1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States